Fabrication and characterization of electrospun polycaprolactone and gelatin composite cuffs for tissue engineered blood vessels
Hannah A. Strobel
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Both authors share first-author credit.
Search for more papers by this authorElizabeth L. Calamari
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Both authors share first-author credit.
Search for more papers by this authorAlexander Beliveau
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Search for more papers by this authorAnjana Jain
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Search for more papers by this authorCorresponding Author
Marsha W. Rolle
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Correspondence to: M. W. Rolle; e-mail: [email protected]Search for more papers by this authorHannah A. Strobel
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Both authors share first-author credit.
Search for more papers by this authorElizabeth L. Calamari
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Both authors share first-author credit.
Search for more papers by this authorAlexander Beliveau
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Search for more papers by this authorAnjana Jain
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Search for more papers by this authorCorresponding Author
Marsha W. Rolle
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts
Correspondence to: M. W. Rolle; e-mail: [email protected]Search for more papers by this authorAbstract
Sewing cuffs incorporated within tissue-engineered blood vessels (TEBVs) enable graft anastomosis in vivo, and secure TEBVs to bioreactors in vitro. Alternative approaches to cuff design are required to achieve cuff integration with scaffold-free TEBVs during tissue maturation. To create porous materials that promote tissue integration, we used electrospinning to fabricate cuffs from polycaprolactone (PCL), PCL blended with gelatin, and PCL coated with gelatin, and evaluated cuff mechanical properties, porosity, and cellular attachment and infiltration. Gelatin blending significantly decreased cuff ultimate tensile stress and failure strain over PCL alone, but no significant differences were observed in elastic modulus or failure load. Interestingly, gelatin incorporation by blending or coating did not produce significant differences in cellular attachment or pore size. We then created tissue tubes by fusing self-assembled smooth muscle cell rings together with electrospun cuffs on either end. After 7 days, rings and cuffs fused seamlessly, and the resulting tubes were harvested for pull-to-failure tests to measure the strength of cuff–tissue integration. Tubes with gelatin-coated PCL cuffs failed more frequently at the cuff–tissue interface compared to PCL and PCL:gelatin blended groups. This work demonstrates that electrospun cuffs integrated successfully with scaffold-free TEBVs, and that the addition of gelatin did not significantly improve cuff integration over PCL alone for this application. Electrospun cuffs may aid cannulation for dynamic culture and testing of tubular constructs during engineered tissue maturation. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 817–826, 2018.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
jbmb33871-sup-0001-suppinfo1.tif2.1 MB |
Supporting Information |
jbmb33871-sup-0001-suppinfo2.tif2.5 MB |
Supporting Information |
jbmb33871-sup-0001-suppinfo3.tif1.4 MB |
Supporting Information |
jbmb33871-sup-0001-suppinfo4.tif106.3 KB |
Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Lawson JH, Glickman MH, Ilzecki M, Jakimowicz T, Jaroszynski A, Peden EK, Pilgrim AJ, Prichard HL, Guziewicz M, Przywara S, Szmidt J, Turek J, Witkiewicz W, Zapotoczny N, Zubilewicz T, Niklason LE. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: Two phase 2 single-arm trials. Lancet 2016; 387: 2026–2034.
- 2 Wystrychowski W, McAllister TN, Zagalski K, Dusserre N, Cierpka L, L'Heureux N. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access. J Vasc Surg 2014; 60: 1353–1357.
- 3 McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, Antonelli J, Kocher A, Zembala M, Cierpka L, Fuente LMdl, L'Heureux N. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: A multicentre cohort study. Lancet 2009; 373: 1440–1446.
- 4 Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010; 139: 431–436.
- 5 Truskey GA, Fernandez CE. Tissue-engineered blood vessels as promising tools for testing drug toxicity. Expert Opin Drug Metab Toxicol 2015; 11: 1021–1024.
- 6 Fernandez CE, Yen RW, Perez SM, Bedell HW, Povsic TJ, Reichert WM, Truskey GA. Human vascular microphysiological system for in vitro drug screening. Sci Rep 2016; 6: 21579.
- 7 L'Heureux N, Stoclet J-C, Auger FA, Lagaud GJ-L, Germain L, Andriantsitohaina R. A human tissue-engineered vascular media: A new model for pharmacological studies of contractile responses. FASEB J 2001; 15: 515–524.
- 8 Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011; 3: 1–11.
- 9 Soletti L, Hong Y, Guan J, Stankus JJ, El-Kurdi MS, Wagner WR, Vorp DA. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater 2010; 6: 110–122.
- 10 Syedain ZH, Meier LA, Lahti MT, Johnson SL, Tranquillo RT. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. Tissue Eng A 2014; 20: 1726–1734.
- 11 Swartz DD, Russell JA, Andreadis ST. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 2005; 288.
- 12 L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361–365.
- 13 Gwyther TA, Hu JZ, Christakis AG, Skorinko JK, Shaw SM, Billiar KL, Rolle MW. Engineered vascular tissue fabricated from aggregated smooth muscle cells. Cells Tissues Organs 2011; 194: 13–24.
- 14 Adebayo O, Hookway TA, Hu JZ, Billiar KL, Rolle MW. Self-assembled smooth muscle cell tissue rings exhibit greater tensile strength than cell-seeded fibrin or collagen gel rings. J Biomed Mater Res A 2013; 101: 428–437.
- 15 Kelm JM, Lorber V, Snedeker JG, Schmidt D, Broggini-Tenzer A, Weisstanner M, Odermatt B, Mol A, Zund G, Hoerstrup SP. A novel concept for scaffold-free vessel tissue engineering: Self-assembly of microtissue building blocks. J Biotechnol 2010; 148: 46–55.
- 16 Watanabe T, Kanda K, Ishibashi-Ueda H, Yaku H, Nakayama Y. Development of biotube vascular grafts incorporating cuffs for easy implantation. J Artif Organs 2007; 10: 10–15.
- 17 Huang AH, Niklason LE. Engineering biological-based vascular grafts using a pulsatile bioreactor. J Visual Exp 2011.
- 18 Syedain ZH, Meier LA, Bjork JW, Lee A, Tranquillo RT. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011; 32: 714–722.
- 19 Konig G, McAllister TN, Dusserre N, Garrido SA, Iyican C, Marini A, Fiorillo A, Avila H, Wystrychowski W, Zagalski K, Maruszewski M, Jones AL, Cierpka L, de la Fuente LM, L'Heureux N. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 2009; 30: 1542–1550.
- 20 Guarino V, Alvarez-Perez M, Cirillo V, Ambrosio L. hMSC interaction with PCL and PCL/gelatin platforms: A comparative study on films and electrospun membranes. J Bioactive Compatib Polym 2011; 26: 144–160.
- 21 Wu S-C, Chang W-H, Dong G-C, Chen K-Y, Chen Y-S, Yao C-H. Cell adhesion and proliferation enhancement by gelatin nanofiber scaffolds. J Bioactive Compatib Polym 2011; 26: 565–577.
- 22 Nottelet B, Pektok E, Mandracchia D, Tille JC, Walpoth B, Gurny R, Moller M. Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts. J Biomed Mater Res A 2009; 89: 865–875.
- 23 Lee J, Tae G, Kim YH, Park IS, Kim SH, Kim SH. The effect of gelatin incorporation into electrospun poly(L-lactide-co-epsilon-caprolactone) fibers on mechanical properties and cytocompatibility. Biomaterials 2008; 29: 1872–1879.
- 24 Zhang Y, Ouyang H, Lim CT, Ramakrishna S, Huang ZM. Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. J Biomed Mater Res B Appl Biomater 2005; 72: 156–165.
- 25 Ma Z, He W, Yong T, Ramakrishna S. Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation. Tissue Eng 2005; 11: 1149–1158.
- 26 de Valence S, Tille JC, Mugnai D, Mrowczynski W, Gurny R, Moller M, Walpoth BH. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. Biomaterials 2012; 33: 38–47.
- 27 Cipitria A, Skelton A, Dargaville TR, Dalton PD, Hutmacher DW. Design, fabrication and characterization of PCL electrospun scaffolds—a review. J Mater Chem 2011; 21: 9419.
- 28 Ghasemi-Mobarakeh L, Prabhakaran MP, Morshed M, Nasr-Esfahani MH, Ramakrishna S. Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering. Biomaterials 2008; 29: 4532–4539.
- 29 Fu W, Liu Z, Feng B, Hu R, He X, Wang H, Yin M, Huang H, Zhang H, Wang W. Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering. Int J Nanomed 2014; 9: 2335–2344.
- 30 McClure MJ, Sell SA, Simpson DG, Walpoth BH, Bowlin GL. A three-layered electrospun matrix to mimic native arterial architecture using polycaprolactone, elastin, and collagen: A preliminary study. Acta Biomater 2010; 6: 2422–2433.
- 31 Panzavolta S, Gioffre M, Focarete ML, Gualandi C, Foroni L, Bigi A. Electrospun gelatin nanofibers: Optimization of genipin cross-linking to preserve fiber morphology after exposure to water. Acta Biomater 2011; 7: 1702–1709.
- 32 Kai D, Prabhakaran MP, Jin G, Ramakrishna S. Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering. J Biomed Mater Res B Appl Biomater 2011; 98: 379–386.
- 33 Heydarkhan-Hagvall S, Schenke-Layland K, Dhanasopon AP, Rofail F, Smith H, Wu BM, Shemin R, Beygui RE, MacLellan WR. Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials 2008; 29: 2907–2914.
- 34 Li X, Xie J, Yuan X, Xia Y. Coating electrospun poly(ɛ-caprolactone) fibers with gelatin and calcium phosphate and their use as biomimetic scaffolds for bone tissue engineering. Langmuir 2008; 24: 14145–14150.
- 35 Hotaling NA, Bharti K, Kriel H, Simon CG, Jr. DiameterJ: A validated open source nanofiber diameter measurement tool. Biomaterials 2015; 61: 327–338.
- 36 Soliman S, Sant S, Nichol JW, Khabiry M, Traversa E, Khademhosseini A. Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. J Biomed Mater Res A 2011; 96: 566–574.
- 37 Gwyther TA, Hu JZ, Billiar KL, Rolle MW. Directed cellular self-assembly to fabricate cell-derived tissue rings for biomechanical analysis and tissue engineering. J Visual Exp 2011: e3366.
- 38 Berry CR. Design and Development of Two Test Fixtures to Test the Longitudinal and Transverse Tensile Properties of Small Diameter Tubular Polymers. DigitalCommons: California Polytechnic State University; 2011.
- 39 Ki CS, Baek DH, Gang KD, Lee KH, Um IC, Park YH. Characterization of gelatin nanofiber prepared from gelatin–formic acid solution. Polymer 2005; 46: 5094–5102.
- 40 Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications: A review. Tissue Eng 2006; 12: 1197–1211.
- 41 Sisson K, Zhang C, Farach-Carson MC, Chase DB, Rabolt JF. Fiber diameters control osteoblastic cell migration and differentiation in electrospun gelatin. J Biomed Mater Res A 2010; 94: 1312–1320.
- 42 Pham QP, Sharma U, Mikos AG. Electrospun poly(E-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: Characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules 2006; 7: 2796–2805.
- 43 Lemson MS, Tordoir JH, Daemen MJ, Kitslaar PJ. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 2000; 19: 336–350.
- 44 Vatankhah E, Semnani D, Prabhakaran MP, Tadayon M, Razavi S, Ramakrishna S. Artificial neural network for modeling the elastic modulus of electrospun polycaprolactone/gelatin scaffolds. Acta Biomater 2014; 10: 709–721.
- 45 McKenna KA, Hinds MT, Sarao RC, Wu PC, Maslen CL, Glanville RW, Babcock D, Gregory KW. Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials. Acta Biomater 2012; 8: 225–233.
- 46 Kim MS, Jun I, Shin YM, Jang W, Kim SI, Shin H. The development of genipin-crosslinked poly(caprolactone) (PCL)/gelatin nanofibers for tissue engineering applications. Macromol Biosci 2010; 10: 91–100.